Sign In
Buy CNS
$80.79
-1.71 (-2.07%)
At Close: Jul 21, 2026
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
05:21pm, Monday, 31'st Mar 2025
NEW YORK , March 31, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the s
Cohen & Steers Closed-End Funds Declare Distributions for April, May and June 2025
04:05pm, Thursday, 27'th Mar 2025
NEW YORK , March 27, 2025 /PRNewswire/ -- The Boards of Directors of the Cohen & Steers Closed-End Funds announced today the monthly distributions for April, May and June 2025, as summarized in the ch
CNS Pharma's Cancer Drug Misses Survival Goal But May Offer Fewer Side Effects
12:05pm, Tuesday, 25'th Mar 2025
CNS Pharmaceuticals, Inc. CNSP on Tuesday announced the primary analysis of its clinical trial evaluating Berubicin for recurrent or progressive Glioblastoma Multiforme (GBM), an aggressive form of
CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme
08:00am, Tuesday, 25'th Mar 2025
Berubicin showed clinically relevant outcomes comparable to Lomustine across multiple endpoints, but not a statistically significant difference in overall survival, the primary endpoint. The safety pr
DUBLIN, March 25, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the publication
Cohen & Steers Real Estate Securities Fund Receives LSEG Lipper Performance Award
09:00am, Monday, 24'th Mar 2025
NEW YORK , March 24, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today that the Cohen & Steers Real Estate Securities Fund (CSZIX) has received a 2025 LSEG Lipper Fund Award for i
Corero Network Security Accelerates AI Integration with Focus on Substance Over Hype
07:00am, Thursday, 13'th Mar 2025
MARLBOROUGH, Mass. , March 13, 2025 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the DDoS protection specialists, today announced the strategic advancement of AI capabilities ac
Contineum Therapeutics to Present at the Stifel 2025 Virtual CNS Forum
04:05pm, Wednesday, 12'th Mar 2025
SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of
Xenon to Present at Stifel 2025 Virtual CNS Forum
04:01pm, Wednesday, 12'th Mar 2025
VANCOUVER, British Columbia and BOSTON, March 12, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, develop
Neurocrine Biosciences to Present at the Stifel 2025 Virtual CNS Forum
04:01pm, Tuesday, 11'th Mar 2025
SAN DIEGO , March 11, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the Stifel 2025 Virtual CNS Forum at 1:30 p.m. Eastern Time on Tuesday, March 18, 2025.
Alnylam to Webcast Presentation at Stifel 2025 Virtual CNS Forum
08:00am, Tuesday, 11'th Mar 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Stifel 20
Dyne Therapeutics to Present at Stifel 2025 Virtual CNS Forum
07:30am, Tuesday, 11'th Mar 2025
WALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetical
Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum
07:00am, Tuesday, 11'th Mar 2025
WATERTOWN, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of
Cohen & Steers Announces the Retirement of Daniel P. Charles, Head of Global Distribution
04:35pm, Monday, 10'th Mar 2025
NEW YORK , March 10, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today that Daniel P. Charles, Executive Vice President and Head of Global Distribution, will retire after 37 years
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for February 2025
04:24pm, Monday, 10'th Mar 2025
NEW YORK , March 10, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $88.6 billion as of February 28, 2025, an increase of $2.1 billion from
